Two Sigma Advisers
WHWK

Two Sigma Advisers’s Whitehawk Therapeutics WHWK Stock Holding History

Two Sigma Advisers’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,400
Closed -$103K – 2300
2025
Q4 		$103K Buy
+42,400
New +$97.3K ﹤0.01% 2222
2025
Q2 		– Sell
-40,969
Closed -$72.9K – 2595
2025
Q1 		$72.9K Sell
40,969
-20,717
-34% -$54.1K ﹤0.01% 2281
2024
Q4 		$195K Buy
61,686
+30,086
+95% +$68.2K ﹤0.01% 2131
2024
Q3 		$65.1K Buy
31,600
+16,300
+107% +$26.4K ﹤0.01% 2201
2024
Q2 		$22.3K Buy
+15,300
New +$28.4K ﹤0.01% 2399
2021
Q3 		– Sell
-1,353
Closed -$34K – 2725
2021
Q2 		$34K Buy
1,353
+500
+59% +$11.4K ﹤0.01% 2397
2021
Q1 		$17K Buy
+853
New +$19.6K ﹤0.01% 2522
2020
Q4 		– Sell
-10,727
Closed -$241K – 2636
2020
Q3 		$241K Buy
+10,727
New +$226K ﹤0.01% 2098

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Two Sigma Advisers's WHWK Position: Q1 2026 in Review

Two Sigma Advisers sold out of Whitehawk Therapeutics (WHWK) in Q1 2026, closing a stake of 42,400 shares — an estimated $103K sold.

Two Sigma Advisers first reported a position in WHWK in Q3 2020 and held it in 8 quarters. The position peaked at $241K in Q3 2020. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Two Sigma Advisers reported no remaining Whitehawk Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 42,400 Whitehawk Therapeutics shares in Q1 2026, an estimated $103K.
  • Two Sigma Advisers first reported a position in Whitehawk Therapeutics in Q3 2020 and held it in 8 quarters.
  • Two Sigma Advisers's Whitehawk Therapeutics position peaked at $241K in Q3 2020.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.